Colorectal Cancer Molecular Diagnostics Market Snapshot 2022 to 2032

The global colorectal cancer molecular diagnostics market garnered a market value of USD 2.35 Billion in 2022 and is expected to accumulate a market value of USD 5.07 Billion by registering a CAGR of 8% in the assessment period 2022 to 2032. Growth of the market can be attributed to increasing cases of cancer along with development in diagnostic laboratories.

Report Attribute Details
Estimated Base Year Value (2021) USD 2.17 Billion
Expected Market Value (2022) USD 2.35 Billion
Anticipated Forecast Value (2032) USD 5.07 Billion
Projected Growth Rate (2022 to 2032) 8% CAGR

Approximately 1.4 million new cases of colorectal cancer are diagnosed each year. Obtaining an early diagnosis is critical as it is currently one of the deadliest cancers, totalling more than 600,000 deaths each year.

Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor in personalized medicine. This, in turn, is increasing the dependency on colorectal cancer molecular diagnostics.

Increasing adoption of high throughput sequencing technologies and identification of therapeutic targets has led to the development of many colorectal molecular diagnostic tests, which are superior to the conventional colorectal cancer molecular diagnostics tests.

Positive market trends and increasing investor confidence in several key players are helping mergers and acquisition activities in the colorectal cancer molecular diagnostics market. The disruption in the global healthcare market due to political factors such as the Obama Care Act, and regulatory framework changes, and other trade barriers, are anticipated to trigger merger and acquisition activities to drive the colorectal cancer molecular diagnostics market consolidation and further intensify the market competition.

Which are Some Prominent Drivers Accelerating the Growth of Colorectal Cancer Molecular Diagnostics?

Increase in research in the pharmaceutical and biotechnology industry is contributing to the growth of the colorectal cancer molecular diagnostics market significantly. In addition, growing automation in laboratories is another factor supporting the growth of the colorectal cancer molecular diagnostics market.

Moreover, the ease of use of colorectal cancer molecular diagnostics, as well as accurate results is supporting the growth of the colorectal cancer molecular diagnostics market. All these factors are increasing the use of colorectal cancer molecular diagnostics.

What are the Challenges Faced by the Colorectal Cancer Molecular Diagnostics Market?

Despite colorectal cancer being common across the globe, many people do not get themselves tested at an early stage. This is owing to the lack of knowledge regarding the problem and its lasting effects on health. In addition, the availability of low-cost alternatives and the high cost of instruments may hinder the growth of the market during the forecast period.

Limited specificity to some diagnostics tests that are unable to distinguish between inflammation and actual symptoms or cancer is another issue being faced by the colorectal cancer molecular diagnostics market.

Increasing Cases of Colorectal Cancer Augmenting Growth of Colorectal Cancer Molecular Diagnostics Market in North America?

American Cancer Society states that 52,580 deaths are expected to occur due to colorectal cancer in 2022 in USA the number of people being diagnosed with colorectal cancer is increasing owing to habits such as smoking, drastic diet changes and stress. Moreover, people suffering from hereditary cancer diseases are likely to suffer from cancer in the region. As the awareness regarding getting diagnosed is increasing, more people have shown an inclination to undergo tests. Furthermore, owing to the increasing automation of labs in the region is positively Inflcuening the growth of the market.

Thus, North America is expected to hold the maximum market share and is expected to register a CAGR of 9% for the global colorectal cancer molecular diagnostics market.

Government Initiatives Contributing to the Growth of Colorectal Cancer Molecular Diagnostics Market in Asia Pacific?

The strong and evolving government support towards research in biotechnology and pharmaceutical industry in Asia Pacific especially in countries like India and China are contributing to the growth of colorectal cancer molecular diagnostics. Reports state that the number of people suffering from colorectal cancer are expected to increase by 2035, especially in India.

Thus, the government of the country is taking measures to spread awareness amongst people to get tested at an early stage. The Asia Pacific colorectal cancer molecular diagnostics market is anticipated to grow at a rapid pace with a maximum CAGR of more than 8% over the forecast period.

Market Competition

Some of the key players in the global Colorectal Cancer Molecular Diagnostics market are Dako, Gen Probe (Hologic), Cepheid, Qiagen, Roche Diagnostics, Bayer Healthcare, Abbott Laboratories, Grifols, Guardant Health, Danaher Corporation, Siemens, Beckton Dickinson, Biomérieux Sa, and Sysmex Corporation. Attributed to the presence of such high number of participants, the market is highly competitive.

  • In May 2022, Guardant Health launched a shield test that simply draws blood to detect the presence of cancer. This test does not require sedation, dietary changes and is less painful. The shield test detects early signs of colorectal cancer signals in the bloodstream.

Report Scope

Report Attribute Details
Growth Rate CAGR of 8% from 2022 to 2032
Market Value in 2022 USD 2.35 Billion
Market Value in 2032 USD 5.07 Billion
Base Year for Estimation 2021
Historical Data 2017 to 2021
Forecast Period 2022 to 2032
Quantitative Units Revenue in USD Million and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered Product Type, Technology, End User, Region
Regions Covered North America; Latin America; Europe; Asia Pacific; Middle East and Africa
Key Countries Profiled USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa
Key Companies Profiled Dako; Gen Probe (Hologic); Cepheid Qiagen; Roche Diagnostics; Bayer Healthcare; Abbott Laboratories; Grifols, Danaher Corporation; Siemens; Beckton Dickinson; Biomérieux Sa ; Guardant Health; Sysmex Corporation
Customization Available Upon Request

Key Segments Profiled in the Colorectal Cancer Molecular Diagnostics Industry Survey

Colorectal Cancer Molecular Diagnostics Market by Product Type:

  • Colorectal Cancer Molecular Diagnostic Instruments
  • Colorectal Cancer Molecular Diagnostic Reagents & Kits
  • Colorectal Cancer Molecular Diagnostic Services

Colorectal Cancer Molecular Diagnostics Market by Technology:

  • PCR-based Colorectal Cancer Molecular Diagnostics
  • Sequencing-based Colorectal Cancer Molecular Diagnostics
  • Mass Spectrometry-based Colorectal Cancer Molecular Diagnostics
  • Transcription Mediated Amplification-based Colorectal Cancer Molecular Diagnostics
  • Chips and Microarrays-based Colorectal Cancer Molecular Diagnostics
  • Isothermal Nucleic Acid Amplification Technology (INAAT) -based Colorectal Cancer Molecular Diagnostics

Colorectal Cancer Molecular Diagnostics Market by End User:

  • Colorectal Cancer Molecular Diagnostics in Hospitals
  • Colorectal Cancer Molecular Diagnostics in Ambulatory Surgical Centers
  • Colorectal Cancer Molecular Diagnostics in Diagnostic Laboratories
  • Colorectal Cancer Molecular Diagnostics in Homecare Settings

Colorectal Cancer Molecular Diagnostics Market by Region:

  • North America Colorectal Cancer Molecular Diagnostics Market
  • Latin America Colorectal Cancer Molecular Diagnostics Market
  • Europe Colorectal Cancer Molecular Diagnostics Market
  • Asia Pacific Colorectal Cancer Molecular Diagnostics Market
  • Middle East & Africa Colorectal Cancer Molecular Diagnostics Market

Table of Content

  • 1. Executive Summary
  • 2. Market Overview
  • 3. Market Background
  • 4. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
  • 5. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
    • 5.1. Colorectal Cancer Molecular Diagnostic Instruments
    • 5.2. Colorectal Cancer Molecular Diagnostic Reagents & Kits
    • 5.3. Services
  • 6. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Technology
    • 6.1. PCR
    • 6.2. Sequencing
    • 6.3. Mass Spectrometry
    • 6.4. Transcription Mediated Amplification
    • 6.5. Chips and Microarrays
    • 6.6. Isothermal Nucleic Acid Amplification Technology
  • 7. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
    • 7.1. Hospitals
    • 7.2. Ambulatory Surgical Centers
    • 7.3. Diagnostic Laboratories
    • 7.4. Homecare Settings
  • 8. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
    • 8.1. North America
    • 8.2. Latin America
    • 8.3. Europe
    • 8.4. East Asia
    • 8.5. South Asia & Pacific
    • 8.6. MEA
  • 9. North America Colorectal Cancer Molecular Diagnostics Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
  • 10. Latin America Colorectal Cancer Molecular Diagnostics Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
  • 11. Europe Colorectal Cancer Molecular Diagnostics Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
  • 12. East Asia Colorectal Cancer Molecular Diagnostics Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
  • 13. South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
  • 14. MEA Colorectal Cancer Molecular Diagnostics Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
  • 15. Key Countries Colorectal Cancer Molecular Diagnostics Market Analysis
  • 16. Market Structure Analysis
  • 17. Competition Analysis
    • 17.1. Agilent Technologies
    • 17.2. Hologic
    • 17.3. Cepheid
    • 17.4. Qiagen
    • 17.5. Roche Diagnostics
    • 17.6. Bayer Healthcare
    • 17.7. Abbott Laboratories
    • 17.8. Grifols
    • 17.9. Danaher Corporation
    • 17.10. Siemens
    • 17.11. Beckton Dickinson
    • 17.12. Biomérieux Sa
    • 17.13. Sysmex Corporation
  • 18. Assumptions & Acronyms Used
  • 19. Research Methodology

List of Tables

Table 1: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 3: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 4: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 5: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 7: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 8: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 9: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 11: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 12: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 13: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 15: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 16: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 17: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 19: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 20: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 21: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 23: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 24: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 25: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 26: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 27: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 28: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032

List of Figures

Figure 1: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032

Figure 2: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 3: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032

Figure 4: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 9: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 10: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 11: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 12: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 13: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 14: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 15: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 16: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 17: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032

Figure 18: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 19: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032

Figure 20: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by Region, 2022-2032

Figure 21: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032

Figure 22: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 23: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032

Figure 24: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 26: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 29: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 30: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 31: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 32: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 33: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 34: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 35: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 36: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 37: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032

Figure 38: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 39: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032

Figure 40: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032

Figure 42: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 43: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032

Figure 44: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 46: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 49: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 50: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 51: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 52: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 53: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 54: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 55: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 56: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 57: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032

Figure 58: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 59: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032

Figure 60: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032

Figure 61: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032

Figure 62: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 63: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032

Figure 64: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 66: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 69: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 70: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 71: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 72: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 73: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 74: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 75: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 76: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 77: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032

Figure 78: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 79: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032

Figure 80: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032

Figure 81: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032

Figure 82: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 83: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032

Figure 84: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 85: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 86: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 89: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 90: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 91: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 92: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 93: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 94: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 95: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 96: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 97: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032

Figure 98: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 99: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032

Figure 100: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032

Figure 101: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032

Figure 102: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 103: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032

Figure 104: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 105: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 106: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 109: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 110: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 111: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 112: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 113: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 114: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 115: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 116: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 117: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032

Figure 118: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 119: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032

Figure 120: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032

Figure 121: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032

Figure 122: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032

Figure 123: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032

Figure 124: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032

Figure 125: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 126: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 127: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 128: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 129: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 130: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 131: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 132: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 133: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 134: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 135: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 136: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 137: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032

Figure 138: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032

Figure 139: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032

Figure 140: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032

Frequently Asked Questions

What is the anticipated growth of the colorectal cancer molecular diagnostics market until 2032?

FMI projects the global colorectal cancer molecular diagnostics market to expand at an 8% value CAGR by 2032

Which region is forecast to be the most lucrative for colorectal cancer molecular diagnostics market growth?

North America is expected to be the most opportunistic colorectal cancer molecular diagnostics market, expanding at a 9% CAGR

Which are some prominent colorectal cancer molecular diagnostics manufacturers?

Dako, Gen Probe (Hologic), Cepheid, Qiagen, Roche Diagnostics, Bayer Healthcare, Abbott Laboratories, Grifols, Danaher Corporation, Siemens, Beckton Dickinson, Biomérieux Sa, and Sysmex Corporation are some prominent colorectal cancer molecular diagnostics market.

Explore In-vitro Diagnostics Devices Insights

Future Market Insights

Colorectal Cancer Molecular Diagnostics Market